Julie Jordan

Insider Reports History

Location
New York, NY
Signature
/s/ Donna M. Cochener, as attorney-in-fact for Julie Jordan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Julie Jordan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Neurogene Inc. Chief Medical Officer Common Stock 13,300 $251,237 $18.89 20 Feb 2026 Direct
Homology Medicines, Inc. Chief Medical Officer Common Stock 7,496 $4,243 $0.5660 03 Aug 2023 Direct
Neurogene Inc. Chief Medical Officer Employee Stock Option (Right to buy) 50,300 26 Mar 2025 Direct
Neurogene Inc. Chief Medical Officer Stock Option (Right to Buy) 29,600 20 Feb 2026 Direct
Homology Medicines, Inc. Chief Medical Officer Restricted Stock Units 0 $1.15 03 Aug 2023 Direct

Insider Reports Filed by Julie Jordan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NGNE Neurogene Inc. 20 Feb 2026 2 $0 4 Chief Medical Officer 24 Feb 2026, 18:49
NGNE Neurogene Inc. 26 Mar 2025 2 $0 4 Chief Medical Officer 28 Mar 2025, 21:28
NGNE Neurogene Inc. 16 Jan 2024 1 $0 4 Chief Medical Officer 18 Jan 2024, 18:48
NGNE Neurogene Inc. 16 Jan 2024 0 $0 3 Chief Medical Officer 18 Jan 2024, 18:45
QTTB Homology Medicines, Inc. 03 Aug 2023 9 -$2,576 4 Chief Medical Officer 07 Aug 2023, 21:39
QTTB Homology Medicines, Inc. 02 Aug 2023 3 -$130 4 Chief Medical Officer 04 Aug 2023, 16:08
QTTB Homology Medicines, Inc. 07 Mar 2023 0 $0 3 Chief Medical Officer 16 Mar 2023, 17:03